These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 23214452)
1. Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors. La Regina G; Bai R; Rensen WM; Di Cesare E; Coluccia A; Piscitelli F; Famiglini V; Reggio A; Nalli M; Pelliccia S; Da Pozzo E; Costa B; Granata I; Porta A; Maresca B; Soriani A; Iannitto ML; Santoni A; Li J; Miranda Cona M; Chen F; Ni Y; Brancale A; Dondio G; Vultaggio S; Varasi M; Mercurio C; Martini C; Hamel E; Lavia P; Novellino E; Silvestri R J Med Chem; 2013 Jan; 56(1):123-49. PubMed ID: 23214452 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of 2-heterocyclyl-3-arylthio-1H-indoles as potent tubulin polymerization and cell growth inhibitors with improved metabolic stability. La Regina G; Bai R; Rensen W; Coluccia A; Piscitelli F; Gatti V; Bolognesi A; Lavecchia A; Granata I; Porta A; Maresca B; Soriani A; Iannitto ML; Mariani M; Santoni A; Brancale A; Ferlini C; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Novellino E; Silvestri R J Med Chem; 2011 Dec; 54(24):8394-406. PubMed ID: 22044164 [TBL] [Abstract][Full Text] [Related]
3. New 6- and 7-heterocyclyl-1H-indole derivatives as potent tubulin assembly and cancer cell growth inhibitors. La Regina G; Bai R; Coluccia A; Naccarato V; Famiglini V; Nalli M; Masci D; Verrico A; Rovella P; Mazzoccoli C; Da Pozzo E; Cavallini C; Martini C; Vultaggio S; Dondio G; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R Eur J Med Chem; 2018 May; 152():283-297. PubMed ID: 29730191 [TBL] [Abstract][Full Text] [Related]
4. New pyrrole derivatives with potent tubulin polymerization inhibiting activity as anticancer agents including hedgehog-dependent cancer. La Regina G; Bai R; Coluccia A; Famiglini V; Pelliccia S; Passacantilli S; Mazzoccoli C; Ruggieri V; Sisinni L; Bolognesi A; Rensen WM; Miele A; Nalli M; Alfonsi R; Di Marcotullio L; Gulino A; Brancale A; Novellino E; Dondio G; Vultaggio S; Varasi M; Mercurio C; Hamel E; Lavia P; Silvestri R J Med Chem; 2014 Aug; 57(15):6531-52. PubMed ID: 25025991 [TBL] [Abstract][Full Text] [Related]
5. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition. Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790 [TBL] [Abstract][Full Text] [Related]
6. 4- and 5-aroylindoles as novel classes of potent antitubulin agents. Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504 [TBL] [Abstract][Full Text] [Related]
7. Arylthioindole inhibitors of tubulin polymerization. 3. Biological evaluation, structure-activity relationships and molecular modeling studies. La Regina G; Edler MC; Brancale A; Kandil S; Coluccia A; Piscitelli F; Hamel E; De Martino G; Matesanz R; Díaz JF; Scovassi AI; Prosperi E; Lavecchia A; Novellino E; Artico M; Silvestri R J Med Chem; 2007 Jun; 50(12):2865-74. PubMed ID: 17497841 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors. Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802 [TBL] [Abstract][Full Text] [Related]
9. Anticancer properties of indole derivatives as IsoCombretastatin A-4 analogues. Pecnard S; Hamze A; Bignon J; Prost B; Deroussent A; Gallego-Yerga L; Peláez R; Paik JY; Diederich M; Alami M; Provot O Eur J Med Chem; 2021 Nov; 223():113656. PubMed ID: 34171660 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines. Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors. Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422 [TBL] [Abstract][Full Text] [Related]
12. Arylthioindoles, potent inhibitors of tubulin polymerization. De Martino G; La Regina G; Coluccia A; Edler MC; Barbera MC; Brancale A; Wilcox E; Hamel E; Artico M; Silvestri R J Med Chem; 2004 Dec; 47(25):6120-3. PubMed ID: 15566282 [TBL] [Abstract][Full Text] [Related]
13. Substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and analogues: synthesis, cytotoxic activity, and study of the mechanism of action. Andreani A; Granaiola M; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Farruggia G; Stefanelli C; Masotti L; Nguyen TL; Hamel E; Shoemaker RH J Med Chem; 2012 Mar; 55(5):2078-88. PubMed ID: 22283430 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization. Romagnoli R; Prencipe F; Oliva P; Kimatrai Salvador M; Brancale A; Ferla S; Hamel E; Viola G; Bortolozzi R; Persoons L; Balzarini J; Liekens S; Schols D Bioorg Chem; 2020 Apr; 97():103665. PubMed ID: 32086053 [TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of a series of pyrano chalcone derivatives containing indole moiety as novel anti-tubulin agents. Wang G; Li C; He L; Lei K; Wang F; Pu Y; Yang Z; Cao D; Ma L; Chen J; Sang Y; Liang X; Xiang M; Peng A; Wei Y; Chen L Bioorg Med Chem; 2014 Apr; 22(7):2060-79. PubMed ID: 24629450 [TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors. Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel quinoline-based analogues of combretastatin A-4 as tubulin polymerisation inhibitors with apoptosis inducing activity and potent anticancer effect. Ibrahim TS; Hawwas MM; Malebari AM; Taher ES; Omar AM; Neamatallah T; Abdel-Samii ZK; Safo MK; Elshaier YAMM J Enzyme Inhib Med Chem; 2021 Dec; 36(1):802-818. PubMed ID: 33730937 [TBL] [Abstract][Full Text] [Related]